| Financial Year |
March 31 2023 |
| Monetary Funds |
302,790,918.44 |
| Held-for-trading Financial Assets |
41,712,630.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
355,003,047.28 |
| Advances to Suppliers |
8,610,533.96 |
| Other Receivables |
2,769,709.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,102,780.82 |
| Dividend Receivable |
-- |
| Inventories |
390,762,071.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,088,328.43 |
| Total Current Assets |
1,184,009,041.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
87,915,548.32 |
| Fixed Assetes |
627,271,875.43 |
| Under-construction Projects |
20,577,820.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,241,144.96 |
| R&D expenses |
-- |
| Goodwill |
1,293,870.09 |
| Long-Term Deferred and Prepaid Expenses |
1,087,739.32 |
| Deferred Income Tax Assets |
24,772,692.13 |
| Other Non-Current Assets |
170,000,000.00 |
| Sub-Total of Non-Current Assets |
994,160,690.92 |
| Total Assets |
2,178,169,732.11 |
| Short-Term Loans |
447,724,719.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
107,751,670.78 |
| Accounts Payable |
109,484,091.86 |
| Accounts Received In Advance |
500,084.01 |
| Employee Compensation Payable |
7,559,796.31 |
| Taxes Payable |
12,005,584.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,474,897.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,059,583.33 |
| Other Current Liabilities |
556,774.60 |
| Sub-Total of Current Liabilities |
763,330,426.37 |
| Long-term Loans |
100,094,722.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
578,427.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
169,565,046.69 |
| Total Liabilities |
932,895,473.06 |
| Paid-In Capital(Or Share Stock) |
375,284,000.00 |
| Capital Surplus |
112,157,508.69 |
| Surplus Reserve |
97,429,510.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
660,403,239.49 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,245,274,259.05 |
| Owner's Equity（Stockholder's Equity） |
1,245,274,259.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,178,169,732.11 |
